Evaluation of the strategies of switching schizophrenia patients to aripiprazole from other antipsychotic agents: combination of pharmacogenomics and therapeutic drug monitoring
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Pharmacogenomic; Therapeutic Use
- 17 May 2012 Biomarkers information updated
- 16 May 2012 Actual patient number is 79 as reported by ClinicalTrials.gov.
- 16 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.